Gemina Laboratories Statistics

Total Valuation

Gemina Laboratories has a market cap or net worth of CAD 33.56 million. The enterprise value is 34.04 million.

Market Cap	33.56M
Enterprise Value	34.04M

Important Dates

The next estimated earnings date is Friday, September 27, 2024.

Earnings Date	Sep 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Gemina Laboratories has 74.57 million shares outstanding. The number of shares has increased by 20.37% in one year.

Shares Outstanding	74.57M
Shares Change (YoY)	+20.37%
Shares Change (QoQ)	+2.36%
Owned by Insiders (%)	1.00%
Owned by Institutions (%)	n/a
Float	36.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.53
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.36

Financial Position

The company has a current ratio of 0.03

Current Ratio	0.03
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.15
Interest Coverage	-269.85

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-195.03%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-869,465
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.25% in the last 52 weeks. The beta is 0.11, so Gemina Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-6.25%
50-Day Moving Average	0.44
200-Day Moving Average	0.47
Relative Strength Index (RSI)	47.78
Average Volume (20 Days)	2,475

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-5.20M
Pretax Income	-5.22M
Net Income	-5.22M
EBITDA	-5.18M
EBIT	-5.20M
Earnings Per Share (EPS)	-0.07

Full Income Statement

Balance Sheet

The company has 990 in cash and 485,326 in debt, giving a net cash position of -484,336 or -0.01 per share.

Cash & Cash Equivalents	990
Total Debt	485,326
Net Cash	-484,336
Net Cash Per Share	-0.01
Equity (Book Value)	-1.59M
Book Value Per Share	-0.02
Working Capital	-2.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.24 million and capital expenditures -41,354, giving a free cash flow of -3.29 million.

Operating Cash Flow	-3.24M
Capital Expenditures	-41,354
Free Cash Flow	-3.29M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Gemina Laboratories does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.37%
Shareholder Yield	-20.37%
Earnings Yield	-16.00%
FCF Yield	-9.79%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a